Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jianguo Cheng, MD, PhD, is Professor of Anesthesiology and Director of Cleveland Clinic Pain Medicine Fellowship Program. He is one of the 70 Best Pain Management Physicians in America (Becker's ASC Review) and is board certified in both Anesthesiology and Pain Medicine by the American Board of Anesthesiology. Dr. Cheng is Vice President for Scientific Affairs of the American Academy of Pain Medicine (AAPM) and Chairman of USA Section of World Institute of Pain (WIP) .
Dr. Cheng has received research grants of more than $4 million from the National Institutes of Health, the Department of Defense, and other funding agencies. He has published more than 190 research papers, review articles, book chapters, and abstracts. His clinical expertise and research interests are in the mechanisms and therapeutic strategies of chronic pain, spinal cord physiology of sensory-motor integration, and clinical application of neuromodulation and interventional therapies.
abdominal and pelvic pain, Abdominal Pain, abdominal pain and spinal cord stimulation for chronic pain, acute postoperative pain management, anesthesia for orthopedic surgery, back, back neuropathic, Back Pain, back/neck pain, cancer pain, CRP, complex regional pain syndrome, evaluation of back and neck pain, headache and orofacial pain, Headaches, interventional pain management, interventional pain management for back and neck pain, Low Back Pain, management of chronic pain, Neck Pain, neuromodulation, neuropathic, neuropathic pain, pain, pain management, pain management including spine, Pediatric Pain, pelvic pain, reflex sympathetic dystrophy, regional anesthesia, research, spinal cord stimulation, spine, spine pain
Awards & Honors
Dr. Cheng is recognized as one of the 70 Best Pain Physicians in the US (Becker's ASC Review), one of 25 Great Physicians in Ohio (Becker's Review), and one of Top 10 Anesthesiologists in Cleveland (Vitals). He has received Patients' Choice Awards for 5 consecutive years (Vitals), Most Compassionate Doctor Award (Vitals), among more than 40 honors from academic, societal, and governmental agencies. As principle investigator, his research has been consistently funded in the last 18 years by grants from the National Institutes of Health, the Department of Defense, and other funding agencies. As educator, he has trained more than 100 postdoctoral fellows, clinical research fellows, and clinical fellows. His achievements in education have been commended by the ACGME and the Cleveland Clinic Education Institute and recognized by a Certification of Distinguished Development from the Cleveland Clinic.
Innovations & Patents
Dr. Cheng holds two US patents and two technology transfers/licensing. He is recipient of the Cleveland Clinic 2012 and 2007 Inventor Awards for his achievements in effectively treating back pain generated from the sacroiliac joint and his innovations of stem cell therapy for chronic pain and opioid tolerance. He is also the inventor of a wheelchair powered by electrical stimulation of paralyzed leg muscles, designed for patients with spinal cord injury and the elderly.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 2/9/2015, Dr. Cheng has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.